PROGRAF 5mg - Tacrolimus by Astellas

    PROGRAF

    5mg
    Specialty Medications

    PROGRAF5mg

    PROGRAF 5mg (Tacrolimus) is a specialty medications medication manufactured by Astellas.

    Generic Name:Tacrolimus
    Manufacturer:Astellas

    Key Benefits

    • Original manufacturer product
    • Competitive wholesale pricing
    • Worldwide delivery
    • 24/7 WhatsApp support

    Contact Us for Pricing

    Get competitive wholesale pricing for PROGRAF 5mg. Our team is available 24/7.

    Direct line: +44 7429 917553

    Licensed Supplier

    Authorized pharmaceutical distributor

    100% Original

    Guaranteed authentic products

    Worldwide Delivery

    International shipping available

    24/7 Support

    WhatsApp support anytime

    About PROGRAF 5mg

    PROGRAF 5mg containing Tacrolimus is a pharmaceutical product manufactured by Astellas. As a licensed pharmaceutical supplier based in Turkey, we provide authentic PROGRAF with competitive wholesale pricing and worldwide delivery. This medication is used in specialty medications treatment protocols. Contact us via WhatsApp for current availability, pricing information, and shipping options. Our experienced team ensures proper handling and timely international delivery for all pharmaceutical orders.

    Common Uses

    • Specialty Medications treatment

    Ready to Order PROGRAF?

    Contact our team via WhatsApp for instant quotes, availability, and shipping information.

    Related Specialty Medications Products

    Explore more specialty medications medications from our catalog

    DEFITELIO 200mg - Defibrotide
    Specialty Medications

    DEFITELIO200mg

    Defibrotide

    Jazz Pharma
    SOLIRIS 300mg - Eculizumab
    Specialty Medications

    SOLIRIS300mg

    Eculizumab

    Alexion
    INFERJECT 500mg - Iron Carboxymaltose
    Specialty Medications

    INFERJECT500mg

    Iron Carboxymaltose

    Abdi Ibrahim
    LUCENTIS 10mg/ml - Ranibizumab
    Specialty Medications

    LUCENTIS10mg/ml

    Ranibizumab

    Novartis